大疱性类天疱疮血清自身抗体反应性与神经精神疾病及抗糖尿病药和抗精神病药使用相关:一项大型前瞻性队列研究
这项前瞻性多中心研究纳入欧洲16个转诊中心的499例大疱性类天疱疮患者,分析诊断时抗BP180 NC16A和抗BP230 IgG ELISA值与合并症及合并用药的关系。结果显示较高的血清抗BP180反应性与神经精神疾病以及胰岛素或抗精神病药使用相关,而与DPP4抑制剂使用相关的抗BP180和抗BP230反应性较低。
要点
- 较高的血清抗BP180反应性与神经精神疾病相关,与特应性和代谢性疾病无关。
- 较高的血清抗BP180反应性与胰岛素或抗精神病药使用相关,与DPP4抑制剂、血小板聚集抑制剂和左甲状腺素无关。
- DPP4抑制剂使用与较低的抗BP180和抗BP230反应性相关,与不使用该药的糖尿病患者相比更明显。
核心结论
- 诊断时自身抗体反应性与神经精神合并症及特定合并用药之间存在关联,提示病理免疫机制与先于临床显性自身免疫性大疱性皮肤病出现的临床状况之间可能存在联系。
研究设计与样本
- 前瞻性多中心研究,纳入欧洲16个转诊中心诊断为大疱性类天疱疮的499例患者。
- 分析诊断时抗BP180 NC16A和抗BP230 IgG ELISA值与通过标准化表格收集的合并症及合并用药的关系。
主要发现
- 观察到较高的血清抗BP180反应性与神经精神疾病相关,但与特应性和代谢性疾病无关。
- 较高的血清抗BP180反应性与胰岛素或抗精神病药使用相关,但与DPP4抑制剂、血小板聚集抑制剂和左甲状腺素使用无关。
- 与不使用DPP4抑制剂的大疱性类天疱疮患者相比,使用DPP4抑制剂与较低的抗BP180和抗BP230反应性相关;与不使用DPP4抑制剂的糖尿病大疱性类天疱疮患者相比,该发现更为明显。
- 在使用胰岛素和抗精神病药的患者中分别也发现抗BP180和抗BP230反应性之间的关联,但在使用血小板聚集抑制剂和左甲状腺素的患者中未发现。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Bullous pemphigoid (BP), the by far most frequent autoimmune blistering skin disease (AIBD), is immunopathologically characterized by autoantibodies against the two hemidesmosomal proteins BP180 (collagen type XVII) and BP230 (BPAG1 or dystonin). Several comorbidities and potentially disease-inducing medication have been described in BP, yet a systematic analysis of these clinically relevant findings and autoantibody reactivities has not been performed. OBJECTIVE: To determine associations of autoantibody reactivities with comorbidities and concomitant medication. METHODS: In this prospective multicenter study, 499 patients diagnosed with BP in 16 European referral centers were included. The relation between anti-BP180 NC16A and anti-BP230 IgG ELISA values at the time of diagnosis as well as comorbidities and concomitant medication collected by a standardized form were analysed. RESULTS: An association between higher serum anti-BP180 reactivity and neuropsychiatric but not atopic and metabolic disorders was observed as well as with the use of insulin or antipsychotics but not with dipeptidyl peptidase-4 (DPP4) inhibitors, inhibitors of platelet aggregation and L-thyroxine. The use of DPP4 inhibitors was associated with less anti-BP180 and anti-BP230 reactivity compared with BP patients without these drugs. This finding was even more pronounced when compared with diabetic BP patients without DPP4 inhibitors. Associations between anti-BP180 and anti-BP230 reactivities were also found in patients using insulin and antipsychotics, respectively, compared with patients without this medication, but not for the use of inhibitors of platelet aggregation, and L-thyroxine. CONCLUSION: Taken together, these data imply a relation between autoantibody reactivities at the time of diagnosis and both neuropsychiatric comorbidities as well as distinct concomitant medication suggesting a link between the pathological immune mechanisms and clinical conditions that precede the clinically overt AIBD.
引用
- Dikmen HO, Yilmaz K, Benoit S, et al. Serum autoantibody reactivity in bullous pemphigoid is associated with neuropsychiatric disorders and the use of antidiabetics and antipsychotics: a large, prospective cohort study. J Eur Acad Dermatol Venereol. 2022. PMID: 35796163. doi:10.1111/jdv.18414
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。